HOME >> BIOLOGY >> NEWS
Einstein researchers demonstrate a novel approach to treating AIDS

November 6, 2006 (Bronx, NY) Using a radically new strategy featuring radioactive "guided missiles," researchers at the Albert Einstein College of Medicine of Yeshiva University have successfully targeted and destroyed human immune cells infected with HIV, the virus that causes AIDS.

"This study in mice supports the idea that radioimmunotherapy might help in treating people infected with HIV," says Dr. Arturo Casadevall, chair of the department of microbiology and immunology at Einstein and a senior author of the study, which appears in the November issue of PLoS Medicine. "More broadly, this work introduces a new approach for treating the many viral infections, from hepatitis C to Ebola, in which viral proteins are expressed on the surface of infected cells."

The Einstein researchers used a technique called radioimmunotherapy, in which radioisotopes are piggy-backed onto antibodies. Once these precision-made molecules are injected into the body, the antibodies home in on a specific protein targetand the radioisotope "warhead" destroys the cell to which that protein is attached.

Radioimmunotherapy is an accepted treatment for several types of cancer including non-Hodgkins lymphoma. But only at Einstein has it been tried against infectious diseasesan idea pioneered by Dr. Ekaterina Dadachova, the study's lead author and an associate professor in the departments of nuclear medicine and microbiology & immunology.

In a series of animal studies beginning in 2001, Dr. Dadachova and her colleagues have successfully used radioimmunotherapy against a variety of disease-causing microbesfirst the major fungal pathogen Cryptocccus neoformans, which can cause life-threatening encephalitis in AIDS patients and other people with weakened immune systems; then a streptococcal bacterium responsible for pneumonia; and now HIV. The researchers zapped the fungi and bacteria directly, but, in the case of HIV, they aimed for the immune cells tha
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
6-Nov-2006


Page: 1 2 3

Related biology news :

1. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
2. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
3. Einstein researchers discover radiation-eating fungi
4. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
5. Einstein researchers discover how a key dietary vitamin is absorbed
6. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device
7. Team at CNSE and Einstein receive grant to develop worlds smallest cancer detection device
8. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
9. Einstein researchers find key to unlocking worlds deadliest malaria parasite
10. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
11. Einstein researchers take the pulse of a gene in living cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... announced that it has entered into a multi-year contract with Merus N.V., ... their translational and clinical research strategy to discover and develop ground-breaking drugs. ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... 01, 2020 , ... Slone Partners , a nationwide ... placement of Julianne Averill , CPA, as Chief Financial Officer at ... implementing key business strategies to accelerate Alveo’s growth as the company advances its ...
(Date:8/12/2020)... (PRWEB) , ... August 11, 2020 , ... ... a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... 2021 and 2022. The network is a consortium of academic research centers in ...
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... and CEO has been named one of the 100 most inspiring individuals in ... 100 honorees are selected based on how they have inspired their colleagues and ...
(Date:7/31/2020)... ... 2020 , ... Diversified Technologies, Inc. has introduced a full ... drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... push-pull configuration; yielding fast fall time for a capacitive load. These all solid-state ...
Breaking Biology Technology:
Cached News: